The influence of depression on patient-reported outcomes for hip-fracture patients 1 year after surgery: a prospective cohort study.


Journal

Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 13 12 2018
accepted: 13 04 2019
pubmed: 28 4 2019
medline: 17 6 2020
entrez: 28 4 2019
Statut: ppublish

Résumé

Depression is common in elderly hip-fracture patients and together with cognitive impairment is associated with increased risk of mortality. We aimed to examine the influence depression has on patient-reported outcome up to 1 year after acute hip fracture. 162 hip-fracture patients participated in the prospective observational cohort study and were followed up at baseline, and 3 and 12 months using patient-reported outcome scores. Patients with cognitive impairment were excluded. Depression was defined as a score ≥ 8 on the depression subscale of the Hospital Anxiety Depression Scale (HADS D), having a diagnosis of depression or being treated with anti-depressant medication. Hip function was assessed using Harris Hip Score (HHS), EQ-5D was used to assess health status and Quality of life, and the Pain Numerical Rating Scale (PRNS) was used to assess pain levels. A linear regression model adjusted for group, age, sex, and ASA class was used to identify risk factors for functional outcome 12 months after fracture. 35 patients were included in the depression group versus 127 in the control group. No statistical differences were found in the demographic data (age, sex, ASA class, fracture type, operation method, living situation, activities of daily living ADL and clinical pathway) between the groups. In the regression model, we found no correlation between depression and the patient-reported outcome. In young elderly hip fracture patients without cognitive dysfunction, depression may not be of major importance for the rehabilitation of hip function in the short term.

Sections du résumé

BACKGROUND BACKGROUND
Depression is common in elderly hip-fracture patients and together with cognitive impairment is associated with increased risk of mortality.
AIM OBJECTIVE
We aimed to examine the influence depression has on patient-reported outcome up to 1 year after acute hip fracture.
METHODS METHODS
162 hip-fracture patients participated in the prospective observational cohort study and were followed up at baseline, and 3 and 12 months using patient-reported outcome scores. Patients with cognitive impairment were excluded. Depression was defined as a score ≥ 8 on the depression subscale of the Hospital Anxiety Depression Scale (HADS D), having a diagnosis of depression or being treated with anti-depressant medication. Hip function was assessed using Harris Hip Score (HHS), EQ-5D was used to assess health status and Quality of life, and the Pain Numerical Rating Scale (PRNS) was used to assess pain levels. A linear regression model adjusted for group, age, sex, and ASA class was used to identify risk factors for functional outcome 12 months after fracture.
RESULTS RESULTS
35 patients were included in the depression group versus 127 in the control group. No statistical differences were found in the demographic data (age, sex, ASA class, fracture type, operation method, living situation, activities of daily living ADL and clinical pathway) between the groups. In the regression model, we found no correlation between depression and the patient-reported outcome.
CONCLUSION CONCLUSIONS
In young elderly hip fracture patients without cognitive dysfunction, depression may not be of major importance for the rehabilitation of hip function in the short term.

Identifiants

pubmed: 31028625
doi: 10.1007/s40520-019-01207-5
pii: 10.1007/s40520-019-01207-5
pmc: PMC7033144
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

247-255

Références

Clin Cases Miner Bone Metab. 2011 Sep;8(3):49-53
pubmed: 22461830
Int Psychogeriatr. 2010 Mar;22(2):246-53
pubmed: 19951458
Am J Geriatr Psychiatry. 2014 Aug;22(8):838-44
pubmed: 23567372
J Am Geriatr Soc. 2016 Nov;64(11):e171-e176
pubmed: 27673273
J Arthroplasty. 2001 Aug;16(5):575-80
pubmed: 11503116
Injury. 2008 Oct;39(10):1147-56
pubmed: 18656868
Ann Rheum Dis. 1978 Aug;37(4):378-81
pubmed: 686873
J Bone Joint Surg Br. 1972 Feb;54(1):61-76
pubmed: 5011747
BMC Musculoskelet Disord. 2016 Sep 20;17(1):398
pubmed: 27646142
Am J Public Health. 1989 Mar;79(3):279-86
pubmed: 2916712
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
J Bone Joint Surg Am. 2012 Nov 7;94(21):1921-8
pubmed: 23014835
J Am Geriatr Soc. 1975 Oct;23(10):433-41
pubmed: 1159263
Int J Geriatr Psychiatry. 2011 Nov;26(11):1136-43
pubmed: 21064116
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
Age Ageing. 2000 Nov;29(6):537-46
pubmed: 11191247
J Behav Med. 2007 Jun;30(3):187-97
pubmed: 17410418
J Affect Disord. 2009 Apr;114(1-3):94-102
pubmed: 18656266
Int J Geriatr Psychiatry. 2004 May;19(5):472-8
pubmed: 15156549
J Am Med Dir Assoc. 2011 Oct;12(8):556-564
pubmed: 21450227
J Am Geriatr Soc. 2007 Jan;55(1):81-6
pubmed: 17233689
Int J Geriatr Psychiatry. 2012 Sep;27(9):879-92
pubmed: 21984056
Health Policy. 1996 Jul;37(1):53-72
pubmed: 10158943
Gen Hosp Psychiatry. 2007 Mar-Apr;29(2):141-6
pubmed: 17336663
Health Qual Life Outcomes. 2017 Oct 4;15(1):193
pubmed: 28978356
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
Psychol Med. 2006 Nov;36(11):1635-45
pubmed: 16863598
Osteoporos Int. 2008 Nov;19(11):1541-7
pubmed: 18330607
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Lancet. 2001 Apr 21;357(9264):1264-5
pubmed: 11418154
Aging Clin Exp Res. 2018 Jun;30(6):643-650
pubmed: 28803357
Int Orthop. 2011 Nov;35(11):1703-11
pubmed: 21301830
Acta Psychiatr Scand. 1997 Oct;96(4):281-6
pubmed: 9350957
Arthritis Care Res (Hoboken). 2015 May;67(6):765-75
pubmed: 25384985
Anesthesiology. 1978 Oct;49(4):239-43
pubmed: 697077
Arch Phys Med Rehabil. 2017 Mar;98(3):500-507
pubmed: 27530770
Health Qual Life Outcomes. 2003 Aug 01;1:29
pubmed: 12914662
Psychogeriatrics. 2014 Jun;14(2):118-23
pubmed: 24954835
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
J Bone Joint Surg Am. 1969 Jun;51(4):737-55
pubmed: 5783851
Psychol Med. 2000 Jul;30(4):921-9
pubmed: 11037100
Injury. 2012 Jun;43(6):676-85
pubmed: 21683355

Auteurs

Paula Kelly-Pettersson (P)

Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.

Bodil Samuelsson (B)

Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.

Maria Unbeck (M)

Department of Molecular Medicine and Surgery, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.

Olav Muren (O)

Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.

Martin Magnéli (M)

Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.

Max Gordon (M)

Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.

André Stark (A)

Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.

Olof Sköldenberg (O)

Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden. olof.skoldenberg@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH